Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum

Ji Hyun Park, Sook in Ryu, Il Hwan Kim

    Research output: Contribution to journalArticlepeer-review


    Xanthelasma palpebrarum (XP) does not regress spontaneously and most patients complain of cosmetic discomfort. This study presents the results of treatment of XP using 1,444 nm Nd:YAG laser. We aim to evaluate the clinical efficacy of a 1,444 nm Nd:YAG laser in XP. Twenty-eight patients with XP treated with 1,444 nm Nd:YAG laser were analyzed retrospectively. A physician scored the results based on the reduction of the initial lesion area under six categories. The results were scored as follows: no effect (0% clearing of xanthelasma area), some response (1–24% clearing), moderate response (25–49% clearing), marked response (50–74% clearing), satisfactory result (75-99% clearing), and excellent result (100% clearing). Twelve patients (42.8%) showed excellent clearance and 10 patients (35.7%) had clearance greater than 75%. Overall, 24 patients (85.7%) showed improvement higher than 50%. Half of the patients (14 patients) ended the treatment with satisfactory results with one treatment session. Including seven patients who ended the treatment after two laser sessions, 21 patients (75%) reported satisfactory results and ended the treatment after 1 to 2 laser sessions. XP treatment with 1,444 nm Nd:YAG laser showed promising results. We believe it can be an effective and safe treatment modality for XP.

    Original languageEnglish
    Pages (from-to)141-145
    Number of pages5
    JournalJournal of Cosmetic and Laser Therapy
    Issue number3
    Publication statusPublished - 2020 Apr 2


    • 1,444 nm Nd:YAG laser
    • Xanthelasma palpebrarum
    • laser treatment

    ASJC Scopus subject areas

    • Surgery
    • Dermatology


    Dive into the research topics of 'Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum'. Together they form a unique fingerprint.

    Cite this